![](https://webarchive.library.unt.edu/eot2008/20090514045349im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20090514045349im_/http://www.cancer.gov/images/spacer.gif)
| A monoclonal antibody being studied in the treatment of certain types of cancer. MDX-010 is made in the laboratory and binds to the molecule CTLA-4 on T cells (a type of white blood cell). MDX-010 may block CTLA-4 and help the immune system kill cancer cells. Also called ipilimumab. |
Previous Definitions: | maytansinoid DM4-conjugated humanized monoclonal antibody huC242, MBL, MC1R, MDL 101,731, MDR modulator CBT-1 | Next Definitions: | MDX-060, mean, mean survival time, measles virus, measurable disease |
|
![](https://webarchive.library.unt.edu/eot2008/20090514045349im_/http://www.cancer.gov/images/spacer.gif) |